Comparing the complications of 2 copper intrauterine devices: T380A and Cu-Safe 300.
This single-blind case-control study compared the complications of 2 intrauterine devices in consecutive referrals for device insertion in clinics of Shaheed Beheshti University of Medical Sciences, Islamic Republic of Iran. Women who met the inclusion criteria (n = 110) were randomly allocated to receive copper T380A (controls) or Cu-Safe 300 (cases). Moderate or severe pain during the device insertion was reported in 69.1% of controls and 47.3% of cases. Bleeding, vertigo and crampy pain at insertion were not significantly different between the groups. After 3 months follow-up, blood spotting was reported in 16.3% and 32.7% of controls and cases respectively. The Cu-Safe-300 group had less pain and menstrual bleeding but copper T380A had less spotting after 3 months. Studies on longer term complications are strongly recommended.
Nahidi
F
F
Department of Midwifery, Shaheed Beheshti University of Medical Sciences and Health Sciences, Tehran, Islamic Republic of Iran. nahidifateme@yahoo.com
Jalalinia
S
S
D000328:Adult; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D004412:Dysmenorrhea / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007433:Intrauterine Device Expulsion; D007435:Intrauterine Devices, Copper / Q000009:adverse effects*; D007492:Iran / Q000453:epidemiology; D008796:Metrorrhagia / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D010146:Pain / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D010147:Pain Measurement; D012720:Severity of Illness Index; D016037:Single-Blind Method; D012959:Socioeconomic Factors; D013997:Time Factors; D014717:Vertigo / Q000453:epidemiology / Q000209:etiology